Literature DB >> 34014786

Detection of multiple sclerosis lesions in the cervical cord: which of the MAGNIMS 'mandatory' non-gadolinium enhanced sagittal sequences is optimal at 3T?

Chian A Chang1, Abigail L Chong1, Ronil V Chandra1,2, Ernest Butler3, Deepa Rajendran3, Kenneth Chuah1, Stephen Stuckey1,2.   

Abstract

BACKGROUND AND
PURPOSE: The magnetic resonance imaging in multiple sclerosis consensus guidelines currently mandate three sagittal non-contrast enhanced sequences of T2-weighted fast spin echo, proton density-weighted fast spin echo and short tau inversion recovery; however, these particular three sequences have not previously been compared at 3T. This study compared T2-weighted fast spin echo, proton density-weighted fast spin echo, short tau inversion recovery as well as the double inversion recovery sequence for the sagittal detection of multiple sclerosis lesions in the cervical spinal cord at 3T.
METHODS: Nineteen multiple sclerosis patients underwent magnetic resonance imaging with 3T sagittal T2-weighted fast spin echo, proton density-weighted fast spin echo, short tau inversion recovery and double inversion recovery between November 2012 and April 2013. Two neuroradiologists independently reviewed the images, and the number of lesions detected on each sequence was recorded. Lesion conspicuity was quantitatively assessed with the lesion-to-cord-contrast ratio and lesion contrast-to-noise ratio. The Wilcoxon signed rank test was performed for statistical analysis.
RESULTS: Proton density-weighted fast spin echo and short tau inversion recovery detected 32% more lesions compared to T2-weighted fast spin echo, and 37% more lesions compared to double inversion recovery. The lesion-to-cord-contrast ratio was highest in short tau inversion recovery, while the lesion contrast-to-noise ratio was highest for proton density-weighted fast spin echo.
CONCLUSIONS: This study provides the necessary evidentiary support at 3T for the magnetic resonance imaging in multiple sclerosis spinal magnetic resonance imaging protocol consensus guidelines. At 3T sagittal proton density-weighted fast spin echo and short tau inversion recovery sequences allowed improved detection of cervical spinal cord multiple sclerosis lesions, compared to T2-weighted fast spin echo and three-dimensional double inversion recovery magnetic resonance imaging. Utilising T2-weighted fast spin echo alone at 3T is insufficient for lesion detection.

Entities:  

Keywords:  MRI; Multiple sclerosis; cervical; spinal cord

Mesh:

Year:  2021        PMID: 34014786      PMCID: PMC8649197          DOI: 10.1177/19714009211017787

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  32 in total

1.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

2.  Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging.

Authors:  F Nelson; A H Poonawalla; P Hou; F Huang; J S Wolinsky; P A Narayana
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

Review 3.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

4.  MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability.

Authors:  G J Lycklama à Nijeholt; F Barkhof; P Scheltens; J A Castelijns; H Adèr; J H van Waesberghe; C Polman; S J Jongen; J Valk
Journal:  AJNR Am J Neuroradiol       Date:  1997 Jun-Jul       Impact factor: 3.825

Review 5.  Motion artifacts in brain and spine MR.

Authors:  R S Hinks; R M Quencer
Journal:  Radiol Clin North Am       Date:  1988-07       Impact factor: 2.303

6.  Multiple sclerosis of the spinal cord: magnetic resonance appearance.

Authors:  K R Thielen; G M Miller
Journal:  J Comput Assist Tomogr       Date:  1996 May-Jun       Impact factor: 1.826

7.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.

Authors:  Jeroen J G Geurts; Petra J W Pouwels; Bernard M J Uitdehaag; Chris H Polman; Frederik Barkhof; Jonas A Castelijns
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

8.  Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis.

Authors:  D Kidd; J W Thorpe; A J Thompson; B E Kendall; I F Moseley; D G MacManus; W I McDonald; D H Miller
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

9.  Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.

Authors:  A Traboulsee; J H Simon; L Stone; E Fisher; D E Jones; A Malhotra; S D Newsome; J Oh; D S Reich; N Richert; K Rammohan; O Khan; E-W Radue; C Ford; J Halper; D Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

10.  Short-Ti inversion-recovery pulse sequence: analysis and initial experience in cancer imaging.

Authors:  A J Dwyer; J A Frank; V J Sank; J W Reinig; A M Hickey; J L Doppman
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

View more
  1 in total

1.  Improved detection of multiple sclerosis lesions with T2-prepared double inversion recovery at 3T.

Authors:  Mauro Costagli; Caterina Lapucci; Domenico Zacà; Nicolò Bruschi; Simona Schiavi; Lucio Castellan; Alto Stemmer; Luca Roccatagliata; Matilde Inglese
Journal:  J Neuroimaging       Date:  2022-07-01       Impact factor: 2.324

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.